Journal of Biomedicines Entrants into the degradome pool: tRNA and snoRNA-derived molecules. Witold Światowy*, Paweł P. Jagodzńśki. *Corresponding author Witold Światowy, Department of Biochemistry and Molecular Biology, Poznań University of Medical Sciences, Poland.

Received Date : April 12, 2024 Accepted Date : April 14, 2024 Published Date : May 14, 2024 ABSTRACT Numerous research have been conducted on RNA- based compounds, revealing new architectures and functionalities that these molecules are capable of. Thanks to next-generation sequencing, very small RNAs have been observed recently, and the number of newly identified RNA molecules is growing quickly. In addition to Observed short oligonucleotides with structures derived from tRNA and snoRNA molecules were found not to be progenitors of known RNA molecules. Researchers have been interested in these structures because of the comparatively high level of tRNA or snoRNA fragment accumulation. Moreover, some parent molecule components were missing. Moreover, the roles of derivatives of well-known RNA molecules differ from those of their parent molecules. Like miRNA, their primary function is to control the expression of genetic information. Furthermore, several of the miRNAs that have been reported are tRNA or snoRNA derivatives. In the lack of a description of the macroeffects that these recently identified compounds impose, the majority of research on them is focused on their detection and analysis. molecular mechanism that gives rise to and drives them. Keywords Noncoding RNA,tRNA,snoRNA,RNA processing,sdRNA,tRF INTRODUCTION Among the most significant chemical groups found in living things are RNA molecules. Initially, it was believed that they only served as an intermediary product in the process of translating genetic information from DNA into proteins. Prior to the identification of ribosomal RNA (rRNA) and transfer RNA (tRNA), which demonstrated that RNA can serve additional purposes in cells [1], non-coding RNA was assumed to be non-functional and worthless. More investigation improved our knowledge of RNA [2]. Next, RNA was separated into two categories: non-coding (ncRNA) and coding (mRNA). At first, RNAs without an open reading frame (ORF) and with a seven-nucleotide cap were categorized as non-coding RNAs (ncRNA). This perspective has evolved, and all RNAs that do not encode proteins are now classified as ncRNAs. [3]. There are two categories of non-coding RNA (ncRNA): interference RNA and housekeeping RNA. Housekeeping RNA is made up of components including rRNA, tRNA, and others whose expression is essential to a cell’s ability to operate normally. Transfermessenger RNA (tmRNA), small nuclear RNA (snRNA), small nucleolar RNA (snoRNA), and a few others. Post- transcriptional gene silencing is the function of microRNA (miRNA), which is categorized as interference RNA [3]. The nomenclature for RNAs may need to be revised in the future years as information regarding ever-newer RNAs becomes available. Terms like long non-coding RNA, short RNA, and microRNA may no longer be appropriate. This needs to be taken into account along with the titles that the RNA is namely, abnormally tiny RNA, as reported in this paper. The tRNA and snoRNA fragments are the molecules from this RNA category that are most commonly reported. The transfer RNA is in charge of supplying the ribosomes with amino acids. They transfer free amino acids to translation sites by binding to them in a particular way. Apart from their primary role of delivering amino acids to ribosomes, they can also be a retrovirus primer, transfer amino acids to other metabolic pathways, and control cell death by cytochrome binding [4]. Because all tRNA molecules must be able to interact with the rRNA in a comparable way, all tRNAs have the shape of a four-leaf clover. rRNA is capable of differentiating D loops in addition to the anticodon loop. T-loops (Fig. 1) as well. These are significant components when considering the molecules that will be covered later. Given the great degree of evolutionarily conserved nature of transporting RNAs, it is possible that molecules generated during the process of their breakdown were among the earliest regulatory elements to arise [5]. An equivalent term for small nucleolar RNA is small nuclear RNA (snRNA), which highlights the precise location of these molecules. Their length ranges from 60 to 300 nucleotides, Review Article 1www.directivepublications.org

Journal of Biomedicines Review Article 2www.directivepublications.org and they are primarily found in the nucleolus but are also seen in Cajal bodies. This particular RNA type is present in both eukaryotes and archaea, which is why they most likely evolved two to three billion years ago. Introns are where snoRNA is most frequently coded in humans. Introns are typically degraded upon mRNA splicing, but snoRNAs are able to circumvent this destiny by building complexes with proteins that we refer to as snoRNPs [5]. The tiny nucleolar RNA is classified into two categories based on structural and functional differences. RNA can have nucleotides chemically modified by C/D and H/ACA snoRNPs. This occurs primarily in ribosomal RNA in translation-related regions like the peptidyl transferase center or mRNA decoding center, but it can also occur in other RNAs like snRNA in eukaryotes, tRNA in archaebacteria, and potentially brain-specific RNA. Mammals’ mRNA (Fig. 2). A suitable alteration of snRNA by soRNA molecules is required for the correct operation of spliceosomes [5]. The C/D family has the ability to methylate 2′-O-ribose because fibrillarin methyltransferase is present. The H/ACE family, on the other hand, is linked to pseudouridine synthetase. A specific nucleotide can be modified via the selective hybridization of snoRNA segments with the appropriate RNA fragment [5]. More than 200 distinct snoRNA molecules exist, but not all of them have been linked to particular target tRNA or snRNA molecules. These are known as orphan snoRNAs, and their roles in the body are yet unknown. 2. RNA DEGRADATION For the cell to remain in a condition of equilibrium, the degradation process is crucial. Cells possess the ability to regulate all levels and reactions. of the proteins. The processes of RNA degradation include the elimination of unnecessary normal RNA, RNA maturation (the processing of precursor molecules), quality control (the removal of particles that have been incorrectly folded or synthesized), post-transcriptional control of gene expression, and defense against non-native RNA (Fig. 3) [6,7]. The deterioration process is a vast and intricate system that still needs to be fully understood. The cleavage reaction is caused by the ribonucleases, which are classified into three classes based on where the phosphodiester bond hydrolysis occurs. The breaking of bonds within the RNA molecule is catalyzed by endoribonuclease, the detachment of a single nucleotide from the 5′ end is catalyzed by 5′-3′ exoribonuclease, and the analogue function is provided on the 3′ end by 3′- 5′ exoribonuclease. Within every subcategory, Enzyme families that recognize different substrates are numerous. While certain enzymes are highly specialized, others can be applied to target sequences that are more degenerate [7, 8]. This variety of ribonucleases demonstrates the significance of this process for the correct operation of the degrading system and is expected to provide the maximum level of reliability.organism and cell [9]. An estimated 60+ distinct RNA-degrading enzymes from multiple families have been identified in humans.[7]. The majority of the mechanisms of degradation that have been studied and explained relate to activities that take place in prokaryotic cells. Mammalian processes are less well characterized than yeast processes among the eukaryotes. Nonetheless, there is a theory that Saccharomyces cerevisiae and mammalian mechanisms are comparable. [8]. The policy plan RNA molecules are made up of two parts: their source and their destination. For cells to operate properly, the presence of RNA molecules must be dynamically controlled. This is because, in addition to synthesising new RNAs, a procedure must be in place to monitor the quality of newly produced particles and degrade them as necessary. This is significant because homeostasis may be upset if a particular mRNA exists for an extended period of time [8]. The two stages of the degradation process are as follows: the first is the identification of a defective particle, which varies greatly amongst organisms. The chosen molecule’s breakdown forms the basis of the second stage. This is the same for nearly all ribonucleases. Although the exact mechanism for identifying molecules with nucleus defects is unknown, it is hypothesized that these molecules cannot proceed rapidly enough to the next phase, whereupon they are picked up by the Trf-Air-Mtr4 polyadenylation complex (TRAMP complex) and designated with a poly tail (A) before being sent down the degradation path. We now have a better understanding of the cytoplasmic breakdown mechanism. The identification of the faulty protein involves various protein components. structure that acknowledges particular drawbacks. The primary cause of degradation in the cytoplasm is the exosome complex, which is comprised of both exonuclease actions [10]. Degradation of no longer- needed mRNA occurs in the cytoplasm. This is accomplished by regulating the transcript’s longevity through the use of a poly tail at the 3′ end and a cap at the 5′ end. The poly (A) tail is 50–250 base pairs long and is bound by various protein components that guarantee the structure’s stability. Poly (A)-specific ribonuclease 3′-5′ PRN exonucleases shorten the tail, and the tail is destined for destruction when it reaches a length of 20–25 nt at the 3′ end. Compared to mRNAs, other RNAs are more stable.such as rRNA and tRNA, but they also occasionally need to be broken down, as in the case of cellular shortages of essential building blocks, rRNA ribophagy, or the dispersion of entire ribosomes.

Journal of Biomedicines Review Article 3www.directivepublications.org 3. STABLE BYPRODUCTS OF DEGRADATION Scientists are seeing ever-tinier structures because of a constantly evolving study technique, mostly because of extremely efficient sequencing. Among other things, they have started to show interest in previously unconsidered very tiny structures of ribonucleic acids, on the order of a dozen or so nucleotides [11]. These short amino acids were first believed to be a temporary byproduct of the breakdown of tRNA, rRNA, or other RNA molecules with well-known and characterized activities. It was believed that these pieces had no biological use until the structure was thoroughly studied. Although the initial research indicates that The discovery that RNA molecules do not break down into single nucleotides was made in 1971. The first indication that functional RNA fragments exist was made in 2008 when researchers discovered that snoRNA fragments functioned similarly to miRNA [5]. It was discovered that severing tRNA stopped the synthesis of viral proteins, acting as a defense against phage T4 [12]. Studies on different particles with structures derived from tRNA, snoRNA, rRNA, or, to a lesser extent, other molecules, have been conducted [5,13,14]. Numerous creatures from all branches of the biological tree have been found to contain particles produced from functional RNAs. tree of life’s evolutionary relationships [15]. They have been discovered in eukaryotes, which includes plants [19], prokaryotes [18], and archaea [16, 17]. Of course, mammals [20, 21]. The fact that the compounds under discussion are so widely distributed implies that they originated early on and were probably one of the main mechanisms regulating gene expression [17]. Scholars who have explored their functioning and described their possibilities have given them different names. They were written as tRF (tRNA-derived RNA fragments), usRNA (unusually small RNA), hcnRNA (high copy number RNA), sitRNA (stress-induced tRNA-derived RNA), or tRNA halves, used interchangeably with tsRNA (tRNA-derived small RNA) due to the lack of a unified nomenclature for RNA fragments derived from known RNA structures [11,13,20,22– 24]. As miRNA, several fragments have been categorized [1,25]. 4. Because tRNAs are the most prevalent group

In the entire RNA degradation pool in eukaryotes, fragments from tRNA cutting tRNAs are the most numerous group in the pool.kind of short RNAs that follow miRNAs, which is why reports of them are most common [22]. Moreover, tRNA fragments have been discovered.in a large number of prokaryotic, archaeal, and eukaryotic organisms [28]. The end of the previous century has one of the earliest references to the existence of the tRNA molecule-cutting mechanism. It has been shown that the E. Coli strain that targets the T4 phage has a defense mechanism that involves chopping tRNALys at the location of the anticodon loop following viral infection to lessen the translation of late phage proteins in phase. These findings, however, have not encouraged researchers to look for further cleavage tRNA-related processes [29]. But there are other locations where tRNA molecules can be cut, resulting in the production of degradants, which is how tRNA fragments were divided and categorized. Based on the tRNA molecule cleavage point and whether the molecules were tRNA halves (tsRNA) or fragments of tRNA (tRF), Huvanger and colleagues described this division [30]. Apart from the bond hydrolysis that occurs within loops of the mature tRNA, multiple cuts in additional locations, and cutting in immature particles were also noted (Fig. 4) [31]. Nonetheless, Collins et al.’s study from 2005 [24] contained one of the earliest reports of the accumulation of tRNA halves. They saw this occurrence in T. thermopile when they were exposed to oxidative stress. Subsequent research has seen similar phenomena with other tRNA derivatives and in different organisms. The accumulation of human, plant, and yeast tRNA half-lives has been noted under the oxidative stress’s impact [32]. Numerous other investigations have also observed the occurrence of fission in the anticodon loop under the influence of stress [32, 33]. One would assume that the production of tRNA halves only occurs in response to stress. Studies have demonstrated, therefore, that this phenomenon also happens in the context of normal physiological function [13, 32]. The most often documented ribonucleases that cause cleavage in the anticodon loop are angiogenin in higher eukaryotes, such as humans [32], and Rny1p in yeast [34]. Upon closer inspection, the idea of cleavage in the anticodon loop remains elusive. Shahbi et al. provided an example of tRNAGlyGCC in their research, where the cleavage site happened four times between 30 and 34 nt, with this tRNA’s GCC anticodon situated between 33 and 35 nt. There was a cut in the anticodon alone, and more than half of the tRNA halves—55%—ended right before the anticodon. occurred extremely infrequently—just 0.04% of the time (Fig. 5) [33]. Several investigations have demonstrated that these enzymes’ primary function in their respective organisms is to split tRNA into two pieces. The RNaz T2 family comprises these enzymes [31]. It’s important to remember that the tRNA halves are not a byproduct of intermediate degradation because they are was believed that these pieces had no biological use until the structure was thoroughly studied. Although the initial research indicates that The discovery that RNA molecules do not break down into single nucleotides was made in 1971. The first indication that functional RNA fragments exist was made in 2008 when researchers discovered that snoRNA fragments

Journal of Biomedicines Review Article 4www.directivepublications.org functioned similarly to miRNA [5]. It was discovered that severing tRNA stopped the synthesis of viral proteins, acting as a defense against phage T4 [12]. Studies on different particles with structures derived from tRNA, snoRNA, rRNA, or, to a lesser extent, other molecules, have been conducted [5,13,14]. Numerous creatures from all branches of the biological tree have been found to contain particles produced from functional RNAs. tree of life’s evolutionary relationships [15]. They have been discovered in eukaryotes, which includes plants [19], prokaryotes [18], and archaea [16, 17]. Of course, mammals [20, 21]. The fact that the compounds under discussion are so widely distributed implies that they originated early on and were probably one of the main mechanisms regulating gene expression [17]. Scholars who have explored their functioning and described their possibilities have given them different names. They were written as tRF (tRNA-derived RNA fragments), usRNA (unusually small RNA), hcnRNA (high copy number RNA), sitRNA (stress-induced tRNA-derived RNA), or tRNA halves, used interchangeably with tsRNA (tRNA-derived small RNA) due to the lack of a unified nomenclature for RNA fragments derived from known RNA structures [11,13,20,22– 24]. As miRNA, several fragments have been categorized [1,25].discovered at comparatively high concentrations, with the other half of the supplied tRNA absent. This shows that the tRNA half is left in a single nucleotide after the destruction of needless tRNA residues. comparatively stable configuration. This demonstrates how this structure might be used [30]. Dnmt2 can occasionally methylate the protective mechanism against tRNA cleavage into halves when stress is present; Schaefer et al. [35] reported this event. Furthermore, it was noted in numerous studies that there was no tRNA loss when the tRNA half-life increased, which may imply that the tRNA halves have certain roles [32]. 5. PATHOPHYSIOLOGY AND TRNA DEGRADANTS’ ROLES Limitation of protein translation by a reduction in the number of tRNAs and tRNA degraders was one of the first connections between the breakdown of tRNA and the increased quantity of tRNA degraders under stressful settings. transport of amino acids is restricted [34]. Studies have demonstrated a lack of association between the elevated level of tRNA fragments and mature tRNA, refuting this idea [36]. Nonetheless, the majority of studies [32] that document an elevated quantity of degradants during a stressful event do not include mature tRNA levels. Establishing a clear correlation between mature tRNA and its derivatives is crucial. Positive associations were observed when the relationship between tRNA halves and cell apoptosis was also investigated. [35]. Among other things, overexpressing Rny1p, the enzyme that forms tRNA helix. The function of Rny1p in the breakdown process was illustrated in the same work. Enzyme Rny1p is kept in vacuoles.and is released while under stress, resulting in an increase in the tRNA half [34]. Although fragments produced from tRNA lack a well-defined mechanism of action, it can be deduced that they are important in stressful situations, as several studies have shown. that they serve as a defense mechanism against the negative consequences of stress [34]. They aid in the development of stress granules [15]. Additionally, it has been noted that a few tRFs are necessary for cell viability. It has been shown that cell death may result from a deficiency in the molecule tRF-1001, which is generated by the cytoplasmic Elac2 endonuclease from pre-tRNA. Furthermore, it has been shown that this tRF is expressed in a variety of cancer cell lines. Because of the higher production of these molecules during cellular proliferation and the lower levels that were noted during circumstances of high cell density and hunger stress [22]. tRFs have the power to control how genetic information is expressed at the transcription and translation levels [25]. Depending on the tRF fragment, regulation can occur in one of two ways: either by directly binding to the molecules of the translational apparatus, the ribosome unit, or by binding to the Argonaute (AGO) protein and the RNA-induced silencing complex (RISC) and initiating the post-transcriptional gene silencing (PTGS) machinery [37]. Certain tRNA-derived particles have the same origins as miRNA or siRNA [37] and can inhibit translation through comparable processes.process, forming complexes with proteins of the AGO family [38]. Additionally, they have the ability to bind RISC complexes and function inside the PTGS machinery, which results in the matrix being cut and degraded and supersession transcription factors silencing the genes. Whether the degradation of mRNA will occur based on the complementarity between the transcript and the non- coding RNA (ncRNA) that joins the silencing complex—in this example, tRF. While partial complementarity only prevents translation, full complementarity causes mRNA to degrade [39]. The tRNA fragment’s well-documented regulation method of expression inside the PTGS apparatus alludes to the CU1276 molecule, which was reported by Maute et al. It is a 22 nt long 5′ fragment of tRF that inhibits RPA1 from being expressed. gene by attachment to the AGO protein. DNA repair and cell proliferation are both regulated by the RPA1 protein. By reducing the expression of the mentioned gene, CU1276 prevents cells from proliferating. In this investigation, a reduced level of these 5′ tRF in lymphoma cells was seen in

Journal of Biomedicines Review Article 5www.directivepublications.org comparison to control cells, both in cell lines and in biopsy samples. This implies that CU1276 is required to regulate the appropriate development of B lymphocytes, which are the source of lymphoma [25]. According to a different well-described study, the functions of tRF vary according on the kind of tissue and cell. Finding a tRNA fragment’s activity in a specific illness instance does not guarantee that the molecule will function in any other in the same manner as another tissue or illness. The example of tRF/mir-1280, which was originally classified as a microRNA but was really produced from tRNALeu including the 5′ end of the parent chemical. There have been reports of many cancer cases exhibiting distinct levels of expression. Blood sample analysis revealed a rise in mir-1280 expression in breast cancer patients with primary cancer, or non-metastatic cancer. Both before and after cancer therapy, blood was analyzed. It was discovered that the tested tRF’s expression dropped down following therapy. According to this discovery, initial cancer cases have elevated expression [40]. The expression of the 5’tRF is increased in colorectal and nonsmall cell lung cancer (NSCLS). On the other hand, there is less expression in pancreatic cancer. The variations in expression in these four distinct cases are sufficiently notable that they can function as illness biomarkers [41]. The Melanoma and colon and rectal carcinomas were similarly found to have lower expression levels; however, in these instances, mir-1280’s function was investigated. It was found that the tested 5′ tRF’s capacity to bind to oncogenes at the 3′ UTR location inhibited those genes’ activity [42]. It has been shown that a proto-oncogene SRC, which is overexpressed in melanoma cells, causes the disease. Reduced expression of SRC and inhibition of cell proliferation and tumor growth were the outcomes of direct injection of mir-1280 or induction of overexpression in melanoma.These investigations demonstrate that mir-1280 has potential therapeutic uses in certain cancer situations [43]. Out of the five ligands in the Notch signaling pathway, JAG2’s expression was reduced in colon cancer by 5′-tRF. In cells of colon and rectal cancer, JAG2 has an significant part in both the survival of individual cells and the acquisition of stem cell characteristics. Tumor development is inhibited by a decrease in JAG2 expression [42]. The second approach involves exerting influence over the components of the translational apparatus, perhaps leading to a translation inhibition. Among these was the capacity to attach 5′-tRFVal to a small ribosome subunit in stressful situations, primarily at low pH. This led to disruptions in the establishment of peptide bonds between successive amino acids. Translation of novel proteins was hindered by impaired peptidyl transferase [16]. A publication by Sobol et al. appears to suggest a similar mechanism, wherein they describe tRF inhibiting translation without AGO’s involvement. proteins and without mRNA complementarity. Although the authors acknowledge that a thorough explanation of the mechanism is necessary, the evidence suggests that ncRNAs formed from tRNA may serve as the primary means of expression control [44]. Following the previously described elements, the Human Multisynthetase Complex (MSC) is another factor that regulates gene expression. It has the ability to bind tRNAs, accelerate protein translation, and bind ribosomes [45]. According to descriptions, degradants have the ability to displace eIF4, a component that initiates translation, so preventing translation from beginning. procedure [46, 47]. 5′tsRNAAla and 5′tsRNACys were found to have translation initiation factors (eIF4) displaced. These compounds had 5’end (5′-TOG motif) oligo-guanine terminal (TOG) motifs, or 4–5 guanine residues at the 5′ end. By purposefully introducing the 5′-TOG motif to the 5′tsRNAMet and obtaining comparable activity, it has been demonstrated that this motif is primarily responsible for the inhibition of translational initiation [46]. Although there is still much to learn about degradant function, specific findings offer some understanding of their pathophysiology and processes. The significance of tRNA fragments under demanding circumstances is supported by several links to pathological diseases. But it’s important to remember that they have an impact on metabolic states as well. 6. THE PATHOPHYSIOLOGY AND ROLES OF CUT SNORNA FRAGMENTS snoRNA fragments are the second most spoken about class of deteriorators. Protozoa [36], viruses [48], and mammals [27], including humans [27,49], have all been shown to exhibit them. Although there have been instances of alternative nomenclature, such as psnoRNA (processing snoRNA) or sno-miRNA (pointing to functional similarity with miRNA), they are typically referred to in the nomenclature as sdRNA (sno-derived RNAs) [50,51]. The naming issue with snoRNA degradants is different from that of derived tRNA, though, as there is no differentiation between those derived from the C/D box and those derived from the H/ACA box. There may not be much exact information available regarding these compounds because some research have not taken these differences into consideration; For instance, the results of a general test for sdRNA particle length range from 18 to 22 nt [48]. Research outlining the origin and length of the short RNAs examined in people provide significantly more accurate data, however it frequently contains contradictions. While molecules from the second group often have lengths of 17–22 nt and occasionally exceed 27 nt, degradants produced from

Journal of Biomedicines Review Article 6www.directivepublications.org H / ACA typically have lengths of 20–24 nt [27,35,49]. Studies started use deep sequencing to look into small-sized RNA in the wake of small non-coding RNAs derived from snoRNA [47]. It has been shown that short RNAs formed from so- called tiny RNAs (snoRNA) can bind proteins belonging to the Argonaute family and subsequently inhibit the expression of certain genes [27, 52]. sdRNAs got started attributable in part to sdRNA that is formed from soRNA ACA45, to be compared to miRNA. Similar to how the tested sdRNA’s precursor Pre-miRNA forms a hairpin structure and is subsequently processed by Drosha-independent Dicer. Additionally, the ACA45-derived sdRNA was shown to recognize mRNA’s 3′UTR regions in the same study. Having the capacity to bind to the Ago1 and Ago2 proteins, thereby post-transcriptionally silencing the expression of the CDC2L6 gene. Since the CDC2L6 gene product is a part of the Mediator Complex, which regulates transcription, the silence of this gene is crucial for the general transcription of genes in mammals [52, 53]. Dicer and Drosha, two enzymes involved in the synthesis of miRNA, are necessary for the formation of sdRNA, according to a different study. The research discovered a lower concentration.global sdRNA in the sample that had lower levels of Drosha and Dicer nuclease expression than the control groups [27]. This work shows that Drosha is necessary for the synthesis of at least some sdRNA. Variations in the degree of expression of some sdRNAs, like tRF or tsRNA, are typical in cancer. Prostate cancer has been linked to elevated levels of SNORD78, while NSCLC has been linked to elevated levels of SNRA42, SNORD33, SNORD66, and SNORD76, among several other factors [54]. The researchers’ observation that sdRNA can bind to AGO proteins in these instances suggests that the proteins may play a role in translation inhibition. These investigations, however, could not clarify the molecular processes underlying these dependencies. In the document outlining Given the elevated expression of sdRNA-93 in breast cancer, it has been observed that the regulation of expression mechanism bears similarities to microRNA. Furthermore, the signal The mechanism influencing sdRNA has been identified. sdRNA-93 influences the metabolism of sarcosine by means of the pipox gene’s identification of its 3′UTR. Sarcosine metabolism is affected by the pipox gene. Nonetheless, the molecular subtypes of breast cancer are influenced by the expression level of sarcosine [55]. The sno-mir-28 molecule, which is derived from the snoRNA molecule SNORD28, is an intriguing target of sdRNA. In breast cancer cells, there is increased expression of both SNORD28 and sno-mir-28. Furthermore, SNORD HOST GEN 1 protein (SNHG1) was found to be substantially increased. The degradant molecule interferes with the p53 protein’s ability to function. A mutation in the gene producing the p53 protein, TP53, has been found to affect more than half of all genes. This protein regulates the expression of a very large number of genes. Sno-mir-28 acknowledges the 3′UTR region of TAF9B and suppresses its expression by forming a complex with the AGO protein. As a component of transcription factor IID (TFIID), the TAF9B protein stabilizes and co-activates the p53 protein. Together with sno-mir-28, TAF9B, and SNHG1, the p53 protein molecule creates a regulatory loop that modifies p53 stability and downregulates p53-dependent pathways. One of the important regulatory molecules in the development of cancer may be the tested degradant, and it may also have an noteworthy oncogene in these illnesses [56]. Because of these parallels between sdRNA and miRNA, known and described miRNAs have been screened in miRBase to see whether or not their snoRNA molecules are the precursors. Pre-miRNAs derived from H/ACA snoRNA, such HBII-99b and SNORD126 [51], as well as molecules derived from C/D snoRNA, like miR-1291/ACA34, miR-1248/ HBI-6, and miR-664/ACA36b [57], have been identified at least in part. Stable evolutionary structures are suggested by the widespread presence of sdRNA in a wide range of taxa, including those that represent primitive organisms like Giardia lamblia [36]. Researchers Scott et al. examined the similarities and differences between miRNA, sdRNA, and noRNA while highlighting the chromosomal similarities that have been preserved over time. They propose that there may have been a common ancestor for miRNA and snoRNA.either that miRNAs are descended from snoRNA [57]. It’s important to note that most derived C/D box snoRNAs preserve the parent molecule’s functional components. Frequently, they have a C box within, with the D cassettes on either side [51]. 7. Viewpoints Research on molecules that can be added to the Degradome pool is still necessary in a significant way. In actuality, every field needs to explain or define this technique. How these molecules are created is the first crucial question. Numerous theories and instances of their development exist. They cannot, however, be applied to every molecule in this pool because they are not entirely described by the molecular account. Environments that favor the development of degradants are also a contentious topic; some writers have discovered that they only appear in stressful situations, while others have stated that they are additionally prevalent in physiological settings. Clarifying the process by which specific molecules develop can aid in the explanation of other fascinating questions regarding these

Journal of Biomedicines Review Article 7www.directivepublications.org molecules, most notably their function. A handful of their roles have already been outlined, but the narrative is yet incomplete. It has previously been shown that while not all of the particles have a miRNA-like function, some do. There are several functions that are not well explained, and this understanding might be expanded. It is important to pay attention to the evolutionary origin of the described particles, which is still unknown. The RNA molecules’ state of being discovered in numerous evolutionary tree branches suggests that they originated as regulatory molecules very early on. Unanswered concerns include whether further regulatory RNAs have developed from tRNA and small RNA. REFERENCES 1. T.R. Cech, J.A. Steitz, The noncoding RNA revolution— trashing old rules to forge new ones, Cell 157 (2014) 77–94. 2. M. Pertea, The human transcriptome: an unfinished story, Genes (Basel) 3 (2012) 344–360. 3. C. Morey, P. Avner, Employment opportunities for non- coding RNAs, FEBS Lett. 567 (2004) 27–34. 4. E.M. Phizicky, A.K. Hopper, tRNA biology charges to the front, Genes Dev. 24 (2010) 1832–1860. 5. Kasprzyk Anna Mleczko Piotr Celichowski Kamilla Bąkowska-Żywicka, M. M., Biologii RNA, Z. & Chemii Bioorga-nicznej Polskiej Akademii Nauk, I. RNA processing — unusual mechanism of generation of novel classes of noncoding RNAs from functional RNAs, Postepy Biochem., 60, (2014). 6. J. Houseley, D. Tollervey, The many pathways of RNA degradation, Cell 136 (2009) 763–776. 7. C.M. Arraiano, F. Mauxion, S.C. Viegas, R.G. Matos, B. Séraphin, Intracellular ribonucleases involved in transcript processing and decay: precision tools for RNA, Biochim. Biophys. Acta - Gene Regul. Mech. 1829 (2013) 491–513. 8. R. Parker, RNA degradation in Saccharomyces cerevisae, Genetics 191 (2012) 671–702. 9. G. Stoecklin, O. Mühlemann, RNA decay mechanisms: specificity through diversity, Biochim. Biophys. Acta - Gene Regul. Mech. 1829 (2013) 487–490. 10. M.K. Doma, R. Parker, RNA quality control in eukaryotes, Cell 131 (2007) 660–668. 11. Z. Li, et al., Characterization of viral and human RNAs smaller than canonical MicroRNAs, J. Virol. 83 (2009) 12751–12758. 12. A. Yudelevich, Specific cleavage of an Escherichia coli leucine transfer RNA following bacteriophage T4 infection, J. Mol. Biol. 60 (1971) 21–29. 13. M. Nowacka, et al., Identification of stable, high copy number, medium-sized RNA degradation intermediates that accumulate in plants under non- stress conditions, Plant Mol. Biol. 83 (2013) 191–204, https://doi. org/10.1007/s11103-013-0079-3. 14. M. Zywicki, K. Bakowska-Zywicka, N. Polacek, Revealing stable processing products from ribosome-associated small RNAs by deep-sequencing data analysis, Nucleic Acids Res. 40 (2012) 4013–4024. 15. S.P. Keam, G. Hutvagner, tRNA-derived fragments (tRFs): emerging new roles for an ancient RNA in the regulation of gene expression, Life (Basel, Switzerland) 5 (2015) 1638–1651. 16. J. Gebetsberger, M. Zywicki, A. Künzi, N. Polacek, tRNA- derived fragments target the ribosome and function as regulatory non-coding RNA in Haloferax volcanii, Archaea (2012) 1–11 2012. 17. J. Babski, et al., Small regulatory RNAs in Archaea, RNA Biol. 11 (2014) 484–493. 18. P. Kumar, J. Anaya, S.B. Mudunuri, A. Dutta, Meta- analysis of tRNA derived RNA fragments reveals that they are evolutionarily conserved and associate with AGO proteins to recognize specific RNA targets, BMC Biol. 12 (2014) 78. 19. L.-C. Hsieh, S.-I. Lin, H.-F. Kuo, T.-J. Chiou, Abundance of tRNA-derived small RNAs in phosphate-starved Arabidopsis roots, Plant Signal. Behav. 5 (2010) 537–539. 20. D. Haussecker, et al., Human tRNA-derived small RNAs in the global regulation of RNA silencing, RNA 16 (2010) 673–695. 21. J.E. Babiarz, J.G. Ruby, Y. Wang, D.P. Bartel, R. Blelloch, Mouse ES cells express endogenous shRNAs, siRNAs, and

Journal of Biomedicines Review Article 8www.directivepublications.org other Microprocessor-independent, Dicer-dependent small RNAs, Genes Dev. 22 (2008) 2773–2785. 22. Y.S. Lee, Y. Shibata, A. Malhotra, A. Dutta, A novel class of small RNAs: tRNAderived RNA fragments (tRFs), Genes Dev. 23 (2009) 2639–2649. 23. Y. Li, et al., Stress-induced tRNA-derived RNAs: a novel class of small RNAs in the primitive eukaryote Giardia lamblia, Nucleic Acids Res. 36 (2008) 6048–6055. 24. S.R. Lee, K. Collins, Starvation-induced cleavage of the tRNA anticodon loop in Tetrahymena thermophila, J. Biol. Chem. 280 (2005) 42744–42749. 25. R.L. Maute, et al., tRNA-derived microRNA modulates proliferation and the DNA damage response and is down-regulated in B cell lymphoma, Proc. Natl. Acad. Sci. 110 (2013) 1404–1409. 26. P. Jackowiak, M. Nowacka, P.M. Strozycki, M. Figlerowicz, RNA degradome–its biogenesis and functions, Nucleic Acids Res. 39 (2011) 7361–7370. 27. R.J. Taft, et al., Small RNAs derived from snoRNAs, RNA 15 (2009) 1233–1240. 28. J. Gebetsberger, N. Polacek, Slicing tRNAs to boost functional ncRNA diversity, RNA Biol. 10 (2013) 1798– 1806. 29. R. Levitz, et al., The optional E. Coli prr locus encodes a latent form of phage T4- induced anticodon nuclease, EMBO J. 9 (1990) 1383–1389. 30. A. Sobala, G. Hutvagner, Transfer RNA-derived fragments: origins, processing, and functions, Wiley Interdiscip. Rev. RNA 2 (2011) 853–862. 31. A. Kanai, Disrupted tRNA genes and tRNA fragments: a perspective on tRNA gene evolution, Life (Basel, Switzerland) 5 (2015) 321–331. 32. D.M. Thompson, C. Lu, P.J. Green, R. Parker, tRNA cleavage is a conserved response to oxidative stress in eukaryotes, RNA 14 (2008) 2095–2103. 33. J.M. Dhahbi, et al., 5′ tRNA halves are present as abundant complexes in serum, concentrated in blood cells, and modulated by aging and calorie restriction, BMC Genom. 14 (2013) 298. 34. D.M. Thompson, R. Parker, The RNase Rny1p cleaves tRNAs and promotes cell death during oxidative stress in Saccharomyces cerevisiae, J. Cell Biol. 185 (2009) 43–50. 35. M. Schaefer, et al., RNA methylation by Dnmt2 protects transfer RNAs against stress-induced cleavage, Genes Dev. 24 (2010) 1590–1595. 36. A.A. Saraiya, C.C. Wang, snoRNA, a Novel Precursor of microRNA in Giardia lamblia, PLoS Pathog. 4 (2008) e1000224. 37. Z. Li, et al., Extensive terminal and asymmetric processing of small RNAs from rRNAs, snoRNAs, snRNAs, and tRNAs, Nucleic Acids Res. 40 (2012) 6787–6799. 38. A.M. Burroughs, et al., Deep-sequencing of human Argonaute-associated small RNAs provides insight into miRNA sorting and reveals Argonaute association with RNA fragments of diverse origin, RNA Biol. 8 (2018) 158–177. 39. M. Zawadzka, P.P. Jagodziński, Exercise-induced epigenetic regulations in in- flammatory related cells, J. Appl. Biomed. 15 (2017) 63–70. 40. I.H. Park, et al., Identification and clinical implications of circulating microRNAs for estrogen receptor-positive breast cancer, Tumour Biol. 35 (2014) 12173–12180.